Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay

被引:101
作者
Bae, HG
Nitsche, A
Teichmann, A
Biel, SS
Niedrig, M
机构
[1] Robert Koch Inst, D-13353 Berlin, Germany
[2] Humboldt Univ, Charite, Med Klin MS Onkol & Hamatol 2, Berlin, Germany
关键词
yellow fever virus; 17D; plaque assay; real-time PCR; TaqMan;
D O I
10.1016/S0166-0934(03)00129-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Yellow fever virus quantitation is performed routinely by cultivation of virus containing samples using susceptible cells. Counting of the resulting plaques provides a marker for the number of infectious particles present in the sample. This assay usually takes up to 5 days before results are obtained and must be carried out under L2 or U laboratory conditions, depending on the yellow fever virus strain used. For clinical diagnosis of yellow fever virus infections the cell culture-based approach takes too long and is of limited practical relevance. Recently, due to its considerable sensitivity, PCR has become a promising method for virus detection. However, whilst PCR can detect virus-specific nucleic acids, it does not allow conclusions to be drawn regarding the infectious potential of the virus detected. Nonetheless, for diagnostic purposes, a rapid, specific and sensitive virus PCR is preferable. Therefore, two independent yellow fever virus-specific real-time PCR assays were established and compared the viral RNA loads to the results of a traditional plaque assay. The estimated ratio of yellow fever virus genomes to infectious particles was between 1000: 1 and 5000: 1; both approaches displayed a comparable precision of < 45%. A significant correlation between genome number as determined by real-time PCR and the corresponding number of plaques in paired samples was found with a Pearson coefficient of correlation of r = 0.88 (P < 0.0001). (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 31 条
[1]   PREDICTING DNA DUPLEX STABILITY FROM THE BASE SEQUENCE [J].
BRESLAUER, KJ ;
FRANK, R ;
BLOCKER, H ;
MARKY, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (11) :3746-3750
[2]   ANTIGENIC RELATIONSHIPS BETWEEN FLAVIVIRUSES AS DETERMINED BY CROSS-NEUTRALIZATION TESTS WITH POLYCLONAL ANTISERA [J].
CALISHER, CH ;
KARABATSOS, N ;
DALRYMPLE, JM ;
SHOPE, RE ;
PORTERFIELD, JS ;
WESTAWAY, EG ;
BRANDT, WE .
JOURNAL OF GENERAL VIROLOGY, 1989, 70 :37-43
[3]   FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATION [J].
CHAMBERS, TJ ;
HAHN, CS ;
GALLER, R ;
RICE, CM .
ANNUAL REVIEW OF MICROBIOLOGY, 1990, 44 :649-688
[4]   A Belgian traveler who acquired yellow fever in the Gambia [J].
Colebunders, R ;
Mariage, JL ;
Coche, JC ;
Pirenne, B ;
Kempinaire, S ;
Hantson, P ;
Van Gompel, A ;
Niedrig, M ;
Van Esbroeck, M ;
Bailey, R ;
Drosten, C ;
Schmitz, H .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (10) :E113-E116
[5]   Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR [J].
de Vries, TJ ;
Fourkour, A ;
Punt, CJA ;
van de Locht, LTF ;
Wobbes, T ;
van den Bosch, S ;
de Rooij, MJM ;
Mensink, EJBM ;
Ruiter, DJ ;
van Muijen, GNP .
BRITISH JOURNAL OF CANCER, 1999, 80 (5-6) :883-891
[6]   HUMAN FATAL YELLOW-FEVER - IMMUNOHISTOCHEMICAL DETECTION OF VIRAL-ANTIGENS IN THE LIVER, KIDNEY AND HEART [J].
DEBRITO, T ;
SIQUEIRA, SAC ;
SANTOS, RTM ;
NASSAR, ES ;
COIMBRA, TLM ;
ALVES, VAF .
PATHOLOGY RESEARCH AND PRACTICE, 1992, 188 (1-2) :177-181
[7]  
DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113
[8]  
Deubel V, 1997, J MED VIROL, V53, P212, DOI 10.1002/(SICI)1096-9071(199711)53:3&lt
[9]  
212::AID-JMV5&gt
[10]  
3.0.CO